Genmab A/S (GMAB)
28.22
-0.18
(-0.63%)
USD |
NASDAQ |
Apr 09, 10:40
Genmab Profit Margin (Quarterly) : 2.93% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Novo Nordisk A/S | 33.98% |
| AbbVie, Inc. | 10.86% |
| Ascendis Pharma A/S | -13.56% |
| Zealand Pharma A/S | -550.1% |
| Bavarian Nordic A/S | -21.14% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.69% |
| Return on Assets | 12.29% |
| Return on Invested Capital | 14.50% |
| Gross Profit Margin (Quarterly) | 92.34% |
| Operating Margin (Quarterly) | 22.97% |
| Return on Net Operating Assets | 19.99% |